Cargando…
cGMP via PKG activates 26S proteasomes and enhances degradation of proteins, including ones that cause neurodegenerative diseases
Because raising cAMP enhances 26S proteasome activity and the degradation of cell proteins, including the selective breakdown of misfolded proteins, we investigated whether agents that raise cGMP may also regulate protein degradation. Treating various cell lines with inhibitors of phosphodiesterase...
Autores principales: | VerPlank, Jordan J. S., Tyrkalska, Sylwia D., Fleming, Angeleen, Rubinsztein, David C., Goldberg, Alfred L. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
National Academy of Sciences
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7321992/ https://www.ncbi.nlm.nih.gov/pubmed/32513741 http://dx.doi.org/10.1073/pnas.2003277117 |
Ejemplares similares
-
The role of cGMP and PKG in cardioprotection
por: Downey, James M, et al.
Publicado: (2009) -
Role of cGMP/PKG in fat tissue
por: Pfeifer, Alexander
Publicado: (2011) -
Structures of human PKG reveal cGMP-selectived activation mechanisms
por: Huang, Gilbert Y, et al.
Publicado: (2013) -
cGMP at the centre of attention: emerging strategies for activating the cardioprotective PKG pathway
por: Park, Min, et al.
Publicado: (2018) -
Construction of novel cGMP FRET-sensors based on PKG from Plasmodium falciparum
por: Calamera, Gaia, et al.
Publicado: (2015)